Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Warren Buffett Teases Tiny Purchase in March Berkshire Filing May Identify the Investment Synopsys Expected to Report Lower Q2 Earnings as Analysts Adjust Forecasts Bessent Sees Substantial Disinflation Ahead as Warsh Assumes Fed Leadership EU Nations Endorse EUUS Data Framework Setting Stage for Formal Adoption Diversified Energy Expands Permian Footprint Through Maverick Natural Resources Acquisition Air T Inc AIRT Q1 2026 Earnings Strong EPS Performance Drives Stock Higher MVIS Q1 2026 Earnings EPS Misses Estimates as Revenue Remains Absent PodcastOne Inc PODC Q1 2026 Earnings Profitability Surprise Drives 9 Stock Rally Maison Solutions Q1 2026 Earnings Significant EPS Miss Amidst Operational Challenges SmartRent Q1 2026 Earnings EPS Miss as Stock Rises 492 on Strategic Progress Evolution Global Acquisition Corp Units EVOXU Holds Steady at 1017 Amid Consolidation Advance Auto Parts AAP Rebounds Stock Rises 276 Eyes Resistance Saratoga Investment Corp Notes SAV Hold Steady Near Par as Yield Attracts Income Investors Wabash National WNC Jumps 458 as Stock Approaches 816 Resistance Zscaler Shares Plunge Over 30 After Weak Revenue Outlook Disappoints Investors Oil Prices Gain as Irans Nuclear Stance Heightens Geopolitical Risk UK Student Loan Inquiry Overwhelmed by 52000 Responses Massive Frustration Over Debt Terms Prediction Markets Signal Growing Probability of Fed Rate Hike by July 2027 CMPS Q1 2026 Earnings Loss Narrower Than Expected as Company Advances Clinical Pipeline Veris Residential Inc VRE Q4 2025 Earnings NarrowerThanExpected Loss Highlights Operational Discipline SRCE Q1 2026 Earnings EPS Misses Expectations Shares Still Edge Higher SNYR Q1 2026 Earnings Stock Rises Despite Massive EPS Miss Amid Operational Challenges Delek Logistics Partners DKL Q1 2026 Earnings EPS Misses Estimates Stock Declines Slightly CLGN Q4 2025 Earnings EPS Misses Estimates as Biotech Continues PreRevenue Phase